Evaluation of Diagnostic Biomarkers


Biomarkers provide a characterized bank of immunology which diverse human peripheral blood nonnuclear cells that access the impact of drugs on immune-related protein biomarkers by using multiple readouts and technology platforms. It is also the platform for 3d polycystic kidney disease assays


  • Asses the risk of cytokine release syndrome
  • Biomarkers screening and identification
  • Assay and platform, using human taste bud epithelial cells

Related Conference of Evaluation of Diagnostic Biomarkers

January 22-23, 2026

26th World Congress on Medicinal Chemistry and Drug Design

Bangkok, Thailand
February 25-26, 2026

16th International Conference on Chemistry Meeting

Paris, France
February 26-27, 2026

29th World Congress on Materials Chemistry

Paris, France
June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Evaluation of Diagnostic Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in